CVS Caremark announced a new cosmetics safety policy as part of its Corporate Social Responsibility report.
CVS Caremark has announced a new cosmetics safety policy as part of its first Corporate Social Responsibility (CSR) report. Responding to consumer and shareholder pressure, the company will remove chemicals linked to adverse health outcomes from its house-branded products and will replace them with safer alternatives. The company will also prompt similar action by its manufacturing partners. The policy further commits the company to continuously evaluate and improve its house-brand products based on emerging science about the links between cosmetic ingredients and health/environmental risks. This new policy follows letters from the Campaign for Safe Cosmetics to the company and ongoing shareholder resolutions filed by Boston Common Asset Management, LLC in 2006 and 2007 and dialogue on cosmetics safety.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
March 20th 2024Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.